New hope for kids with HIV: Easier-to-Take medicine in testing
NCT ID NCT06139796
Summary
This study aimed to test a new, child-friendly tablet version of an existing HIV medicine (darunavir/ritonavir) for children aged 3 and older. The goal was to find the right dose, check if it was safe, and see if kids could take it easily. The trial was designed to enroll children with HIV but was withdrawn before any participants joined.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine Children's Foundation
Kampala, Uganda, 72052, Uganda
-
Centre Hospitalier National d'Enfants Albert Royer
Dakar, Senegal, 25755, Senegal
-
Centre Mère et Enfant de la Fondation Chantal Biya
Yaoundé, Cameroon, 1, Cameroon
-
Joint Clinical Research Centre (JCRC)
Kampala, Uganda
-
University of Zimbabwe Clinical Research Centre (UZCRC)
Harare, Zimbabwe, Zimbabwe
Conditions
Explore the condition pages connected to this study.